Review
doi: 10.1136/bmj.295.6607.1158.
Psoriatic science
Affiliations
- PMID: 3120922
- PMCID: PMC1248236
- DOI: 10.1136/bmj.295.6607.1158
Item in Clipboard
Review
Psoriatic science
Br Med J (Clin Res Ed).
.
No abstract available
Similar articles
-
Tumour necrosis factor-alpha does not influence proliferation and differentiation of healthy and psoriatic keratinocytes in a skin-equivalent model.Acta Derm Venereol. 2000 Nov-Dec;80(6):416-20. doi: 10.1080/000155500300012792. Acta Derm Venereol. 2000. PMID: 11243633
-
Cultured psoriatic fibroblasts from involved and uninvolved sites have a partial but not absolute resistance to the proliferation-inhibition activity of 1,25-dihydroxyvitamin D3.Proc Natl Acad Sci U S A. 1985 Aug;82(16):5409-12. doi: 10.1073/pnas.82.16.5409. Proc Natl Acad Sci U S A. 1985. PMID: 2991921 Free PMC article.
-
Development of an in vitro psoriatic skin model by tissue engineering.J Dermatol Sci. 2009 Jan;53(1):19-25. doi: 10.1016/j.jdermsci.2008.07.009. Epub 2008 Sep 9. J Dermatol Sci. 2009. PMID: 18783923
-
[Current aspects of the pathogenesis of skin manifestations in psoriasis vulgaris].Hautarzt. 1976 Aug;27(8):363-4. Hautarzt. 1976. PMID: 182658 Review. German.
-
Experimental models for psoriasis.J Invest Dermatol. 1990 Nov;95(5 Suppl):56S-58S. doi: 10.1111/1523-1747.ep12505791. J Invest Dermatol. 1990. PMID: 16788635 Review.
Cited by
-
Psoriasis, T cells and autoimmunity.J R Soc Med. 1996 Oct;89(10):600. doi: 10.1177/014107689608901035. J R Soc Med. 1996. PMID: 8976908 Free PMC article. No abstract available.
-
Lupus anticoagulant in psoriatic-type arthropathy.J R Soc Med. 1989 Aug;82(8):505-6. doi: 10.1177/014107688908200826. J R Soc Med. 1989. PMID: 2506348 Free PMC article. No abstract available.
-
FPL 62064, a topically active 5-lipoxygenase/cyclooxygenase inhibitor.Agents Actions. 1990 Jun;30(3-4):432-42. doi: 10.1007/BF01966309. Agents Actions. 1990. PMID: 2117338
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical